Latest oppositions filed by Zentiva, K.s.

This table presents recent patent oppositions filed by Zentiva, K.s. against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP4070788Pharmaceutical FormulationsGILEAD SCIENCES, INC.Dec 11, 2023
EP3294283Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTIS AGDec 8, 2023
EP4070787Pharmaceutical FormulationsGILEAD SCIENCES, INC.Nov 29, 2023
EP2139494Pharmaceutical Formulations Containing Dapagliflozin Propylene Glycol HydrateASTRAZENECA ABDec 10, 2020
EP3294285Cabazitaxel And Its Use For Treating CancerAVENTIS PHARMA S.A.Sep 18, 2020
EP3335708Administration Of Gamma Hydroxybutyrate With Monocarboxylate TransportersJAZZ PHARMACEUTICALS IRELAND LIMITEDSep 2, 2020
EP3038654New UseNOVARTIS AGJul 23, 2020
EP2371361Methods To Mobilize Progenitor/Stem CellsGENZYME CORPORATIONMay 7, 2020
EP3395339Rapid Dissolution Formulation Of A Cinacalcet HclAMGENJan 17, 2020
EP3103448Pharmaceutical Compositions Comprising An S1P ModulatorNOVARTIS AGDec 9, 2019